Index of /rulepatterns/data-v3/data_per_entity/umab

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]dbr-Abituzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 587  
[ ]dbr-Abituzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Abituzumab-sub-10.ttl.bz22021-05-12 00:38 419  
[ ]dbr-Abrilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 517  
[ ]dbr-Abrilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Abrilumab-sub-10.ttl.bz22021-05-12 00:38 475  
[ ]dbr-Actoxumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Actoxumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 261  
[ ]dbr-Actoxumab-sub-10.ttl.bz22021-05-12 00:38 475  
[ ]dbr-Adalimumab-obj-10.ttl.bz22021-05-12 00:38 238  
[ ]dbr-Adalimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 877  
[ ]dbr-Adalimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 191  
[ ]dbr-Adalimumab-sub-10.ttl.bz22021-05-12 00:38 1.1K 
[ ]dbr-Adecatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Adecatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Adecatumumab-sub-10.ttl.bz22021-05-12 00:38 530  
[ ]dbr-Aducanumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.8K 
[ ]dbr-Aducanumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Aducanumab-sub-10.ttl.bz22021-05-12 00:38 501  
[ ]dbr-Alemtuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Alemtuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 491  
[ ]dbr-Alemtuzumab-sub-10.ttl.bz22021-05-12 00:38 920  
[ ]dbr-Alirocumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Alirocumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Alirocumab-sub-10.ttl.bz22021-05-12 00:38 803  
[ ]dbr-Anifrolumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 906  
[ ]dbr-Anifrolumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Anifrolumab-sub-10.ttl.bz22021-05-12 00:38 636  
[ ]dbr-Anrukinzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 357  
[ ]dbr-Anrukinzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Anrukinzumab-sub-10.ttl.bz22021-05-12 00:38 545  
[ ]dbr-Apolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 764  
[ ]dbr-Apolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Apolizumab-sub-10.ttl.bz22021-05-12 00:38 454  
[ ]dbr-Ascrinvacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 373  
[ ]dbr-Ascrinvacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 122  
[ ]dbr-Ascrinvacumab-sub-10.ttl.bz22021-05-12 00:38 483  
[ ]dbr-Aselizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 364  
[ ]dbr-Aselizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Aselizumab-sub-10.ttl.bz22021-05-12 00:38 461  
[ ]dbr-Atezolizumab-obj-10.ttl.bz22021-05-12 00:38 163  
[ ]dbr-Atezolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 464  
[ ]dbr-Atezolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 252  
[ ]dbr-Atezolizumab-sub-10.ttl.bz22021-05-12 00:38 838  
[ ]dbr-Atorolimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 234  
[ ]dbr-Atorolimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Atorolimumab-sub-10.ttl.bz22021-05-12 00:38 458  
[ ]dbr-Avelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 581  
[ ]dbr-Avelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Avelumab-sub-10.ttl.bz22021-05-12 00:38 871  
[ ]dbr-Bapineuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Bapineuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bapineuzumab-sub-10.ttl.bz22021-05-12 00:38 571  
[ ]dbr-Belimumab-obj-10.ttl.bz22021-05-12 00:38 203  
[ ]dbr-Belimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 695  
[ ]dbr-Belimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 297  
[ ]dbr-Belimumab-sub-10.ttl.bz22021-05-12 00:38 894  
[ ]dbr-Benralizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Benralizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 203  
[ ]dbr-Benralizumab-sub-10.ttl.bz22021-05-12 00:38 893  
[ ]dbr-Bertilimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Bertilimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bertilimumab-sub-10.ttl.bz22021-05-12 00:38 446  
[ ]dbr-Bevacizumab-obj-10.ttl.bz22021-05-12 00:38 203  
[ ]dbr-Bevacizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 809  
[ ]dbr-Bevacizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bevacizumab-sub-10.ttl.bz22021-05-12 00:38 1.1K 
[ ]dbr-Bezlotoxumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Bezlotoxumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Bezlotoxumab-sub-10.ttl.bz22021-05-12 00:38 807  
[ ]dbr-Bimagrumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Bimagrumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bimagrumab-sub-10.ttl.bz22021-05-12 00:38 477  
[ ]dbr-Bimekizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 592  
[ ]dbr-Bimekizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bimekizumab-sub-10.ttl.bz22021-05-12 00:38 445  
[ ]dbr-Bivatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Bivatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bivatuzumab-sub-10.ttl.bz22021-05-12 00:38 341  
[ ]dbr-Bleselumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 520  
[ ]dbr-Bleselumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Bleselumab-sub-10.ttl.bz22021-05-12 00:38 518  
[ ]dbr-Blosozumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 939  
[ ]dbr-Blosozumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Blosozumab-sub-10.ttl.bz22021-05-12 00:38 527  
[ ]dbr-Bococizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 710  
[ ]dbr-Bococizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Bococizumab-sub-10.ttl.bz22021-05-12 00:38 696  
[ ]dbr-Brazikumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 432  
[ ]dbr-Brazikumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Brazikumab-sub-10.ttl.bz22021-05-12 00:38 534  
[ ]dbr-Briakinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 796  
[ ]dbr-Briakinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Briakinumab-sub-10.ttl.bz22021-05-12 00:38 548  
[ ]dbr-Brodalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 848  
[ ]dbr-Brodalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Brodalumab-sub-10.ttl.bz22021-05-12 00:38 584  
[ ]dbr-Brolucizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Brolucizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 262  
[ ]dbr-Brolucizumab-sub-10.ttl.bz22021-05-12 00:38 827  
[ ]dbr-Brontictuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 441  
[ ]dbr-Brontictuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Brontictuzumab-sub-10.ttl.bz22021-05-12 00:38 515  
[ ]dbr-Burosumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Burosumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 266  
[ ]dbr-Burosumab-sub-10.ttl.bz22021-05-12 00:38 793  
[ ]dbr-Camrelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 689  
[ ]dbr-Camrelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 211  
[ ]dbr-Camrelizumab-sub-10.ttl.bz22021-05-12 00:38 490  
[ ]dbr-Canakinumab-obj-10.ttl.bz22021-05-12 00:38 212  
[ ]dbr-Canakinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Canakinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 268  
[ ]dbr-Canakinumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Caplacizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 961  
[ ]dbr-Caplacizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 207  
[ ]dbr-Caplacizumab-sub-10.ttl.bz22021-05-12 00:38 910  
[ ]dbr-Carlumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Carlumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 218  
[ ]dbr-Carlumab-sub-10.ttl.bz22021-05-12 00:38 505  
[ ]dbr-Cedelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 454  
[ ]dbr-Cedelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Cedelizumab-sub-10.ttl.bz22021-05-12 00:38 430  
[ ]dbr-Cirmtuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 493  
[ ]dbr-Cirmtuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 367  
[ ]dbr-Cirmtuzumab-sub-10.ttl.bz22021-05-12 00:38 399  
[ ]dbr-Cixutumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.7K 
[ ]dbr-Cixutumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Cixutumumab-sub-10.ttl.bz22021-05-12 00:38 637  
[ ]dbr-Clazakizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Clazakizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 309  
[ ]dbr-Clazakizumab-sub-10.ttl.bz22021-05-12 00:38 595  
[ ]dbr-Conatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Conatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Conatumumab-sub-10.ttl.bz22021-05-12 00:38 583  
[ ]dbr-Crenezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 609  
[ ]dbr-Crenezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 248  
[ ]dbr-Crenezumab-sub-10.ttl.bz22021-05-12 00:38 504  
[ ]dbr-Crizanlizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Crizanlizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 228  
[ ]dbr-Crizanlizumab-sub-10.ttl.bz22021-05-12 00:38 687  
[ ]dbr-Crotedumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 412  
[ ]dbr-Crotedumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Crotedumab-sub-10.ttl.bz22021-05-12 00:38 532  
[ ]dbr-Dacetuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 641  
[ ]dbr-Dacetuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 154  
[ ]dbr-Dacetuzumab-sub-10.ttl.bz22021-05-12 00:38 570  
[ ]dbr-Daclizumab-obj-10.ttl.bz22021-05-12 00:38 163  
[ ]dbr-Daclizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 939  
[ ]dbr-Daclizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 136  
[ ]dbr-Daclizumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Dalotuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 365  
[ ]dbr-Dalotuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Dalotuzumab-sub-10.ttl.bz22021-05-12 00:38 520  
[ ]dbr-Daratumumab-obj-10.ttl.bz22021-05-12 00:38 161  
[ ]dbr-Daratumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Daratumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 673  
[ ]dbr-Daratumumab-sub-10.ttl.bz22021-05-12 00:38 834  
[ ]dbr-Demcizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 687  
[ ]dbr-Demcizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Demcizumab-sub-10.ttl.bz22021-05-12 00:38 318  
[ ]dbr-Denosumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Denosumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 106  
[ ]dbr-Denosumab-sub-10.ttl.bz22021-05-12 00:38 943  
[ ]dbr-Diridavumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 460  
[ ]dbr-Diridavumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Diridavumab-sub-10.ttl.bz22021-05-12 00:38 450  
[ ]dbr-Domagrozumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 425  
[ ]dbr-Domagrozumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Domagrozumab-sub-10.ttl.bz22021-05-12 00:38 530  
[ ]dbr-Drozitumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Drozitumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 286  
[ ]dbr-Drozitumab-sub-10.ttl.bz22021-05-12 00:38 540  
[ ]dbr-Duligotuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 870  
[ ]dbr-Duligotuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 302  
[ ]dbr-Duligotuzumab-sub-10.ttl.bz22021-05-12 00:38 438  
[ ]dbr-Dupilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Dupilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 262  
[ ]dbr-Dupilumab-sub-10.ttl.bz22021-05-12 00:38 756  
[ ]dbr-Durvalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Durvalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 543  
[ ]dbr-Durvalumab-sub-10.ttl.bz22021-05-12 00:38 840  
[ ]dbr-Dusigitumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 561  
[ ]dbr-Dusigitumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 248  
[ ]dbr-Dusigitumab-sub-10.ttl.bz22021-05-12 00:38 568  
[ ]dbr-Duvortuxizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 431  
[ ]dbr-Duvortuxizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Duvortuxizumab-sub-10.ttl.bz22021-05-12 00:38 489  
[ ]dbr-Eculizumab-obj-10.ttl.bz22021-05-12 00:38 410  
[ ]dbr-Eculizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Eculizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 221  
[ ]dbr-Eculizumab-sub-10.ttl.bz22021-05-12 00:38 958  
[ ]dbr-Efalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Efalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Efalizumab-sub-10.ttl.bz22021-05-12 00:38 608  
[ ]dbr-Efungumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Efungumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Efungumab-sub-10.ttl.bz22021-05-12 00:38 757  
[ ]dbr-Eldelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 814  
[ ]dbr-Eldelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Eldelumab-sub-10.ttl.bz22021-05-12 00:38 460  
[ ]dbr-Elotuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 695  
[ ]dbr-Elotuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 182  
[ ]dbr-Elotuzumab-sub-10.ttl.bz22021-05-12 00:38 860  
[ ]dbr-Emactuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 734  
[ ]dbr-Emactuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Emactuzumab-sub-10.ttl.bz22021-05-12 00:38 631  
[ ]dbr-Emapalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 470  
[ ]dbr-Emapalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 268  
[ ]dbr-Emapalumab-sub-10.ttl.bz22021-05-12 00:38 728  
[ ]dbr-Emibetuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 546  
[ ]dbr-Emibetuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 129  
[ ]dbr-Emibetuzumab-sub-10.ttl.bz22021-05-12 00:38 524  
[ ]dbr-Emicizumab-obj-10.ttl.bz22021-05-12 00:38 166  
[ ]dbr-Emicizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Emicizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Emicizumab-sub-10.ttl.bz22021-05-12 00:38 759  
[ ]dbr-Enavatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 372  
[ ]dbr-Enavatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Enavatuzumab-sub-10.ttl.bz22021-05-12 00:38 526  
[ ]dbr-Enoblituzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 646  
[ ]dbr-Enoblituzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Enoblituzumab-sub-10.ttl.bz22021-05-12 00:38 485  
[ ]dbr-Enoticumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 316  
[ ]dbr-Enoticumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Enoticumab-sub-10.ttl.bz22021-05-12 00:38 440  
[ ]dbr-Epratuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 543  
[ ]dbr-Epratuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 208  
[ ]dbr-Epratuzumab-sub-10.ttl.bz22021-05-12 00:38 582  
[ ]dbr-Eptinezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 846  
[ ]dbr-Eptinezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 492  
[ ]dbr-Eptinezumab-sub-10.ttl.bz22021-05-12 00:38 694  
[ ]dbr-Erenumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 963  
[ ]dbr-Erenumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 290  
[ ]dbr-Erenumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Erlizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 606  
[ ]dbr-Erlizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Erlizumab-sub-10.ttl.bz22021-05-12 00:38 471  
[ ]dbr-Etaracizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 873  
[ ]dbr-Etaracizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 375  
[ ]dbr-Etaracizumab-sub-10.ttl.bz22021-05-12 00:38 541  
[ ]dbr-Etrolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 951  
[ ]dbr-Etrolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Etrolizumab-sub-10.ttl.bz22021-05-12 00:38 593  
[ ]dbr-Evinacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.7K 
[ ]dbr-Evinacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Evinacumab-sub-10.ttl.bz22021-05-12 00:38 528  
[ ]dbr-Evolocumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 860  
[ ]dbr-Evolocumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Evolocumab-sub-10.ttl.bz22021-05-12 00:38 760  
[ ]dbr-Exbivirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 269  
[ ]dbr-Exbivirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Exbivirumab-sub-10.ttl.bz22021-05-12 00:38 500  
[ ]dbr-Farletuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 613  
[ ]dbr-Farletuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Farletuzumab-sub-10.ttl.bz22021-05-12 00:38 545  
[ ]dbr-Fasinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 586  
[ ]dbr-Fasinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Fasinumab-sub-10.ttl.bz22021-05-12 00:38 532  
[ ]dbr-Felvizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 246  
[ ]dbr-Felvizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 236  
[ ]dbr-Felvizumab-sub-10.ttl.bz22021-05-12 00:38 496  
[ ]dbr-Fezakinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 345  
[ ]dbr-Fezakinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Fezakinumab-sub-10.ttl.bz22021-05-12 00:38 542  
[ ]dbr-Ficlatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 766  
[ ]dbr-Ficlatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Ficlatuzumab-sub-10.ttl.bz22021-05-12 00:38 596  
[ ]dbr-Figitumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 926  
[ ]dbr-Figitumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Figitumumab-sub-10.ttl.bz22021-05-12 00:38 634  
[ ]dbr-Flanvotumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 516  
[ ]dbr-Flanvotumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 226  
[ ]dbr-Flanvotumab-sub-10.ttl.bz22021-05-12 00:38 572  
[ ]dbr-Fletikumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 507  
[ ]dbr-Fletikumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Fletikumab-sub-10.ttl.bz22021-05-12 00:38 510  
[ ]dbr-Flotetuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 458  
[ ]dbr-Flotetuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 254  
[ ]dbr-Flotetuzumab-sub-10.ttl.bz22021-05-12 00:38 584  
[ ]dbr-Fontolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 751  
[ ]dbr-Fontolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Fontolizumab-sub-10.ttl.bz22021-05-12 00:38 572  
[ ]dbr-Foralumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 711  
[ ]dbr-Foralumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 242  
[ ]dbr-Foralumab-sub-10.ttl.bz22021-05-12 00:38 498  
[ ]dbr-Foravirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 320  
[ ]dbr-Foravirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Foravirumab-sub-10.ttl.bz22021-05-12 00:38 528  
[ ]dbr-Fremanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Fremanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 421  
[ ]dbr-Fremanezumab-sub-10.ttl.bz22021-05-12 00:38 1.1K 
[ ]dbr-Fresolimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 744  
[ ]dbr-Fresolimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Fresolimumab-sub-10.ttl.bz22021-05-12 00:38 538  
[ ]dbr-Fulranumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Fulranumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 214  
[ ]dbr-Fulranumab-sub-10.ttl.bz22021-05-12 00:38 573  
[ ]dbr-Galcanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.4K 
[ ]dbr-Galcanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 291  
[ ]dbr-Galcanezumab-sub-10.ttl.bz22021-05-12 00:38 826  
[ ]dbr-Ganitumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 640  
[ ]dbr-Ganitumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 245  
[ ]dbr-Ganitumab-sub-10.ttl.bz22021-05-12 00:38 613  
[ ]dbr-Gantenerumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Gantenerumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 292  
[ ]dbr-Gantenerumab-sub-10.ttl.bz22021-05-12 00:38 606  
[ ]dbr-Gevokizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 793  
[ ]dbr-Gevokizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 130  
[ ]dbr-Gevokizumab-sub-10.ttl.bz22021-05-12 00:38 555  
[ ]dbr-Golimumab-obj-10.ttl.bz22021-05-12 00:38 207  
[ ]dbr-Golimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Golimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 121  
[ ]dbr-Golimumab-sub-10.ttl.bz22021-05-12 00:38 971  
[ ]dbr-Guselkumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 371  
[ ]dbr-Guselkumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 262  
[ ]dbr-Guselkumab-sub-10.ttl.bz22021-05-12 00:38 606  
[ ]dbr-Ianalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 548  
[ ]dbr-Ianalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Ianalumab-sub-10.ttl.bz22021-05-12 00:38 411  
[ ]dbr-Ibalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 917  
[ ]dbr-Ibalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Ibalizumab-sub-10.ttl.bz22021-05-12 00:38 796  
[ ]dbr-Icrucumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 472  
[ ]dbr-Icrucumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 335  
[ ]dbr-Icrucumab-sub-10.ttl.bz22021-05-12 00:38 524  
[ ]dbr-Idarucizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Idarucizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 308  
[ ]dbr-Idarucizumab-sub-10.ttl.bz22021-05-12 00:38 803  
[ ]dbr-Imalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Imalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Imalumab-sub-10.ttl.bz22021-05-12 00:38 362  
[ ]dbr-Imgatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 442  
[ ]dbr-Imgatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Imgatuzumab-sub-10.ttl.bz22021-05-12 00:38 572  
[ ]dbr-Inclacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 388  
[ ]dbr-Inclacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Inclacumab-sub-10.ttl.bz22021-05-12 00:38 483  
[ ]dbr-Inebilizumab-obj-10.ttl.bz22021-05-12 00:38 212  
[ ]dbr-Inebilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 909  
[ ]dbr-Inebilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 411  
[ ]dbr-Inebilizumab-sub-10.ttl.bz22021-05-12 00:38 861  
[ ]dbr-Intetumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 646  
[ ]dbr-Intetumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Intetumumab-sub-10.ttl.bz22021-05-12 00:38 524  
[ ]dbr-Ipilimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 901  
[ ]dbr-Ipilimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Ipilimumab-sub-10.ttl.bz22021-05-12 00:38 971  
[ ]dbr-Iratumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 898  
[ ]dbr-Iratumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Iratumumab-sub-10.ttl.bz22021-05-12 00:38 518  
[ ]dbr-Istiratumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 600  
[ ]dbr-Istiratumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Istiratumab-sub-10.ttl.bz22021-05-12 00:38 602  
[ ]dbr-Itolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 458  
[ ]dbr-Itolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 270  
[ ]dbr-Itolizumab-sub-10.ttl.bz22021-05-12 00:38 489  
[ ]dbr-Ixekizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 911  
[ ]dbr-Ixekizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Ixekizumab-sub-10.ttl.bz22021-05-12 00:38 944  
[ ]dbr-Labetuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 778  
[ ]dbr-Labetuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 206  
[ ]dbr-Labetuzumab-sub-10.ttl.bz22021-05-12 00:38 525  
[ ]dbr-Lampalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Lampalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Lampalizumab-sub-10.ttl.bz22021-05-12 00:38 561  
[ ]dbr-Lanadelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Lanadelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 207  
[ ]dbr-Lanadelumab-sub-10.ttl.bz22021-05-12 00:38 774  
[ ]dbr-Landogrozumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 566  
[ ]dbr-Landogrozumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Landogrozumab-sub-10.ttl.bz22021-05-12 00:38 532  
[ ]dbr-Lebrikizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Lebrikizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Lebrikizumab-sub-10.ttl.bz22021-05-12 00:38 764  
[ ]dbr-Lenzilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 468  
[ ]dbr-Lenzilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Lenzilumab-sub-10.ttl.bz22021-05-12 00:38 495  
[ ]dbr-Lerdelimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 725  
[ ]dbr-Lerdelimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Lerdelimumab-sub-10.ttl.bz22021-05-12 00:38 496  
[ ]dbr-Letolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 473  
[ ]dbr-Letolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Letolizumab-sub-10.ttl.bz22021-05-12 00:38 515  
[ ]dbr-Lexatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 763  
[ ]dbr-Lexatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Lexatumumab-sub-10.ttl.bz22021-05-12 00:38 518  
[ ]dbr-Libivirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 228  
[ ]dbr-Libivirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Libivirumab-sub-10.ttl.bz22021-05-12 00:38 500  
[ ]dbr-Ligelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Ligelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 216  
[ ]dbr-Ligelizumab-sub-10.ttl.bz22021-05-12 00:38 485  
[ ]dbr-Lintuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Lintuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 135  
[ ]dbr-Lintuzumab-sub-10.ttl.bz22021-05-12 00:38 442  
[ ]dbr-Lirilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 532  
[ ]dbr-Lirilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Lirilumab-sub-10.ttl.bz22021-05-12 00:38 499  
[ ]dbr-Lucatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Lucatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 168  
[ ]dbr-Lucatumumab-sub-10.ttl.bz22021-05-12 00:38 542  
[ ]dbr-Lumretuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 421  
[ ]dbr-Lumretuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Lumretuzumab-sub-10.ttl.bz22021-05-12 00:38 483  
[ ]dbr-Mapatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 585  
[ ]dbr-Mapatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Mapatumumab-sub-10.ttl.bz22021-05-12 00:38 494  
[ ]dbr-Matuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 716  
[ ]dbr-Matuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 263  
[ ]dbr-Matuzumab-sub-10.ttl.bz22021-05-12 00:38 568  
[ ]dbr-Mavrilimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Mavrilimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Mavrilimumab-sub-10.ttl.bz22021-05-12 00:38 525  
[ ]dbr-Mepolizumab-obj-10.ttl.bz22021-05-12 00:38 216  
[ ]dbr-Mepolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 567  
[ ]dbr-Mepolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 375  
[ ]dbr-Mepolizumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Metelimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 764  
[ ]dbr-Metelimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 209  
[ ]dbr-Metelimumab-sub-10.ttl.bz22021-05-12 00:38 518  
[ ]dbr-Milatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Milatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 198  
[ ]dbr-Milatuzumab-sub-10.ttl.bz22021-05-12 00:38 519  
[ ]dbr-Mirikizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 581  
[ ]dbr-Mirikizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 239  
[ ]dbr-Mirikizumab-sub-10.ttl.bz22021-05-12 00:38 510  
[ ]dbr-Mogamulizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Mogamulizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Mogamulizumab-sub-10.ttl.bz22021-05-12 00:38 837  
[ ]dbr-Monalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 371  
[ ]dbr-Monalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Monalizumab-sub-10.ttl.bz22021-05-12 00:38 379  
[ ]dbr-Morolimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 225  
[ ]dbr-Morolimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Morolimumab-sub-10.ttl.bz22021-05-12 00:38 454  
[ ]dbr-Motavizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 754  
[ ]dbr-Motavizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 356  
[ ]dbr-Motavizumab-sub-10.ttl.bz22021-05-12 00:38 633  
[ ]dbr-Namilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Namilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Namilumab-sub-10.ttl.bz22021-05-12 00:38 524  
[ ]dbr-Narnatumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 443  
[ ]dbr-Narnatumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Narnatumab-sub-10.ttl.bz22021-05-12 00:38 516  
[ ]dbr-Natalizumab-obj-10.ttl.bz22021-05-12 00:38 229  
[ ]dbr-Natalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.6K 
[ ]dbr-Natalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 163  
[ ]dbr-Natalizumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Nebacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 457  
[ ]dbr-Nebacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Nebacumab-sub-10.ttl.bz22021-05-12 00:38 466  
[ ]dbr-Necitumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 895  
[ ]dbr-Necitumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 263  
[ ]dbr-Necitumumab-sub-10.ttl.bz22021-05-12 00:38 833  
[ ]dbr-Nemolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 963  
[ ]dbr-Nemolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Nemolizumab-sub-10.ttl.bz22021-05-12 00:38 628  
[ ]dbr-Nesvacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 684  
[ ]dbr-Nesvacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Nesvacumab-sub-10.ttl.bz22021-05-12 00:38 519  
[ ]dbr-Nimotuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Nimotuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 147  
[ ]dbr-Nimotuzumab-sub-10.ttl.bz22021-05-12 00:38 671  
[ ]dbr-Nivolumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 686  
[ ]dbr-Nivolumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Nivolumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Obinutuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 927  
[ ]dbr-Obinutuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 182  
[ ]dbr-Obinutuzumab-sub-10.ttl.bz22021-05-12 00:38 825  
[ ]dbr-Ocaratuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 933  
[ ]dbr-Ocaratuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Ocaratuzumab-sub-10.ttl.bz22021-05-12 00:38 470  
[ ]dbr-Ocrelizumab-obj-10.ttl.bz22021-05-12 00:38 219  
[ ]dbr-Ocrelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Ocrelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 508  
[ ]dbr-Ocrelizumab-sub-10.ttl.bz22021-05-12 00:38 851  
[ ]dbr-Ofatumumab-obj-10.ttl.bz22021-05-12 00:38 162  
[ ]dbr-Ofatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.6K 
[ ]dbr-Ofatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 257  
[ ]dbr-Ofatumumab-sub-10.ttl.bz22021-05-12 00:38 1.0K 
[ ]dbr-Olaratumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 904  
[ ]dbr-Olaratumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 203  
[ ]dbr-Olaratumab-sub-10.ttl.bz22021-05-12 00:38 874  
[ ]dbr-Oleclumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 503  
[ ]dbr-Oleclumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Oleclumab-sub-10.ttl.bz22021-05-12 00:38 475  
[ ]dbr-Olokizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Olokizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 577  
[ ]dbr-Olokizumab-sub-10.ttl.bz22021-05-12 00:38 496  
[ ]dbr-Omalizumab-obj-10.ttl.bz22021-05-12 00:38 271  
[ ]dbr-Omalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 694  
[ ]dbr-Omalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 262  
[ ]dbr-Omalizumab-sub-10.ttl.bz22021-05-12 00:38 895  
[ ]dbr-Onartuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 468  
[ ]dbr-Onartuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 277  
[ ]dbr-Onartuzumab-sub-10.ttl.bz22021-05-12 00:38 512  
[ ]dbr-Ontuxizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 944  
[ ]dbr-Ontuxizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 217  
[ ]dbr-Ontuxizumab-sub-10.ttl.bz22021-05-12 00:38 465  
[ ]dbr-Opicinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 693  
[ ]dbr-Opicinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Opicinumab-sub-10.ttl.bz22021-05-12 00:38 488  
[ ]dbr-Orticumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 378  
[ ]dbr-Orticumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Orticumab-sub-10.ttl.bz22021-05-12 00:38 397  
[ ]dbr-Otelixizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 694  
[ ]dbr-Otelixizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Otelixizumab-sub-10.ttl.bz22021-05-12 00:38 573  
[ ]dbr-Otlertuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 603  
[ ]dbr-Otlertuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Otlertuzumab-sub-10.ttl.bz22021-05-12 00:38 442  
[ ]dbr-Oxelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 367  
[ ]dbr-Oxelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Oxelumab-sub-10.ttl.bz22021-05-12 00:38 483  
[ ]dbr-Ozanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Ozanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Ozanezumab-sub-10.ttl.bz22021-05-12 00:38 459  
[ ]dbr-Ozoralizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 585  
[ ]dbr-Ozoralizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Ozoralizumab-sub-10.ttl.bz22021-05-12 00:38 440  
[ ]dbr-Palivizumab-obj-10.ttl.bz22021-05-12 00:38 261  
[ ]dbr-Palivizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Palivizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 550  
[ ]dbr-Palivizumab-sub-10.ttl.bz22021-05-12 00:38 928  
[ ]dbr-Pamrevlumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 514  
[ ]dbr-Pamrevlumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Pamrevlumab-sub-10.ttl.bz22021-05-12 00:38 481  
[ ]dbr-Panitumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 938  
[ ]dbr-Panitumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 405  
[ ]dbr-Panitumumab-sub-10.ttl.bz22021-05-12 00:38 822  
[ ]dbr-Panobacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 446  
[ ]dbr-Panobacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Panobacumab-sub-10.ttl.bz22021-05-12 00:38 517  
[ ]dbr-Parsatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 505  
[ ]dbr-Parsatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 240  
[ ]dbr-Parsatuzumab-sub-10.ttl.bz22021-05-12 00:38 471  
[ ]dbr-Pascolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 484  
[ ]dbr-Pascolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Pascolizumab-sub-10.ttl.bz22021-05-12 00:38 514  
[ ]dbr-Pateclizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 355  
[ ]dbr-Pateclizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 353  
[ ]dbr-Pateclizumab-sub-10.ttl.bz22021-05-12 00:38 555  
[ ]dbr-Patritumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 331  
[ ]dbr-Patritumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Patritumab-sub-10.ttl.bz22021-05-12 00:38 416  
[ ]dbr-Pembrolizumab-obj-10.ttl.bz22021-05-12 00:38 231  
[ ]dbr-Pembrolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Pembrolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 466  
[ ]dbr-Pembrolizumab-sub-10.ttl.bz22021-05-12 00:38 1.2K 
[ ]dbr-Perakizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 500  
[ ]dbr-Perakizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 130  
[ ]dbr-Perakizumab-sub-10.ttl.bz22021-05-12 00:38 459  
[ ]dbr-Pertuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Pertuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 319  
[ ]dbr-Pertuzumab-sub-10.ttl.bz22021-05-12 00:38 678  
[ ]dbr-Pexelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 655  
[ ]dbr-Pexelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Pexelizumab-sub-10.ttl.bz22021-05-12 00:38 529  
[ ]dbr-Pidilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Pidilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Pidilizumab-sub-10.ttl.bz22021-05-12 00:38 479  
[ ]dbr-Placulumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 526  
[ ]dbr-Placulumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Placulumab-sub-10.ttl.bz22021-05-12 00:38 522  
[ ]dbr-Plozalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 494  
[ ]dbr-Plozalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 128  
[ ]dbr-Plozalizumab-sub-10.ttl.bz22021-05-12 00:38 495  
[ ]dbr-Ponezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 635  
[ ]dbr-Ponezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 266  
[ ]dbr-Ponezumab-sub-10.ttl.bz22021-05-12 00:38 560  
[ ]dbr-Pritumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Pritumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 262  
[ ]dbr-Pritumumab-sub-10.ttl.bz22021-05-12 00:38 531  
[ ]dbr-Quilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 407  
[ ]dbr-Quilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 130  
[ ]dbr-Quilizumab-sub-10.ttl.bz22021-05-12 00:38 491  
[ ]dbr-Radretumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 589  
[ ]dbr-Radretumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Radretumab-sub-10.ttl.bz22021-05-12 00:38 480  
[ ]dbr-Rafivirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 221  
[ ]dbr-Rafivirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Rafivirumab-sub-10.ttl.bz22021-05-12 00:38 575  
[ ]dbr-Ralpancizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 405  
[ ]dbr-Ralpancizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Ralpancizumab-sub-10.ttl.bz22021-05-12 00:38 477  
[ ]dbr-Ramucirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 655  
[ ]dbr-Ramucirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Ramucirumab-sub-10.ttl.bz22021-05-12 00:38 837  
[ ]dbr-Ranibizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Ranibizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 321  
[ ]dbr-Ranibizumab-sub-10.ttl.bz22021-05-12 00:38 870  
[ ]dbr-Ravulizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 702  
[ ]dbr-Ravulizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Ravulizumab-sub-10.ttl.bz22021-05-12 00:38 898  
[ ]dbr-Raxibacumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 871  
[ ]dbr-Raxibacumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Raxibacumab-sub-10.ttl.bz22021-05-12 00:38 519  
[ ]dbr-Refanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 412  
[ ]dbr-Refanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 128  
[ ]dbr-Refanezumab-sub-10.ttl.bz22021-05-12 00:38 479  
[ ]dbr-Regavirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 232  
[ ]dbr-Regavirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Regavirumab-sub-10.ttl.bz22021-05-12 00:38 427  
[ ]dbr-Reslizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.6K 
[ ]dbr-Reslizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 165  
[ ]dbr-Reslizumab-sub-10.ttl.bz22021-05-12 00:38 840  
[ ]dbr-Rilotumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Rilotumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Rilotumumab-sub-10.ttl.bz22021-05-12 00:38 592  
[ ]dbr-Rinucumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 453  
[ ]dbr-Rinucumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Rinucumab-sub-10.ttl.bz22021-05-12 00:38 481  
[ ]dbr-Risankizumab-obj-10.ttl.bz22021-05-12 00:38 167  
[ ]dbr-Risankizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 838  
[ ]dbr-Risankizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 239  
[ ]dbr-Risankizumab-sub-10.ttl.bz22021-05-12 00:38 894  
[ ]dbr-Robatumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 858  
[ ]dbr-Robatumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 186  
[ ]dbr-Robatumumab-sub-10.ttl.bz22021-05-12 00:38 618  
[ ]dbr-Roledumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 370  
[ ]dbr-Roledumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 427  
[ ]dbr-Roledumab-sub-10.ttl.bz22021-05-12 00:38 418  
[ ]dbr-Romosozumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.4K 
[ ]dbr-Romosozumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 402  
[ ]dbr-Romosozumab-sub-10.ttl.bz22021-05-12 00:38 699  
[ ]dbr-Rontalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 490  
[ ]dbr-Rontalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Rontalizumab-sub-10.ttl.bz22021-05-12 00:38 584  
[ ]dbr-Rosmantuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 439  
[ ]dbr-Rosmantuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Rosmantuzumab-sub-10.ttl.bz22021-05-12 00:38 491  
[ ]dbr-Rovelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.7K 
[ ]dbr-Rovelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 223  
[ ]dbr-Rovelizumab-sub-10.ttl.bz22021-05-12 00:38 481  
[ ]dbr-Ruplizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 696  
[ ]dbr-Ruplizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Ruplizumab-sub-10.ttl.bz22021-05-12 00:38 483  
[ ]dbr-Samalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 342  
[ ]dbr-Samalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Samalizumab-sub-10.ttl.bz22021-05-12 00:38 517  
[ ]dbr-Sarilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Sarilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Sarilumab-sub-10.ttl.bz22021-05-12 00:38 848  
[ ]dbr-Satralizumab-obj-10.ttl.bz22021-05-12 00:38 211  
[ ]dbr-Satralizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 763  
[ ]dbr-Satralizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 212  
[ ]dbr-Satralizumab-sub-10.ttl.bz22021-05-12 00:38 797  
[ ]dbr-Secukinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 729  
[ ]dbr-Secukinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Secukinumab-sub-10.ttl.bz22021-05-12 00:38 720  
[ ]dbr-Seribantumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 435  
[ ]dbr-Seribantumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 253  
[ ]dbr-Seribantumab-sub-10.ttl.bz22021-05-12 00:38 495  
[ ]dbr-Sevirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 357  
[ ]dbr-Sevirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Sevirumab-sub-10.ttl.bz22021-05-12 00:38 385  
[ ]dbr-Sibrotuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 473  
[ ]dbr-Sibrotuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Sibrotuzumab-sub-10.ttl.bz22021-05-12 00:38 491  
[ ]dbr-Sifalimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 708  
[ ]dbr-Sifalimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 243  
[ ]dbr-Sifalimumab-sub-10.ttl.bz22021-05-12 00:38 584  
[ ]dbr-Simtuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 788  
[ ]dbr-Simtuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 130  
[ ]dbr-Simtuzumab-sub-10.ttl.bz22021-05-12 00:38 476  
[ ]dbr-Siplizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 799  
[ ]dbr-Siplizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Siplizumab-sub-10.ttl.bz22021-05-12 00:38 453  
[ ]dbr-Sirukumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 700  
[ ]dbr-Sirukumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 251  
[ ]dbr-Sirukumab-sub-10.ttl.bz22021-05-12 00:38 600  
[ ]dbr-Solanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 728  
[ ]dbr-Solanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Solanezumab-sub-10.ttl.bz22021-05-12 00:38 580  
[ ]dbr-Spartalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 519  
[ ]dbr-Spartalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Spartalizumab-sub-10.ttl.bz22021-05-12 00:38 502  
[ ]dbr-Stamulumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 865  
[ ]dbr-Stamulumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 199  
[ ]dbr-Stamulumab-sub-10.ttl.bz22021-05-12 00:38 575  
[ ]dbr-Suptavumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 821  
[ ]dbr-Suptavumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 203  
[ ]dbr-Suptavumab-sub-10.ttl.bz22021-05-12 00:38 496  
[ ]dbr-Suvizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 208  
[ ]dbr-Suvizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 337  
[ ]dbr-Suvizumab-sub-10.ttl.bz22021-05-12 00:38 492  
[ ]dbr-Suvratoxumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 509  
[ ]dbr-Suvratoxumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 241  
[ ]dbr-Suvratoxumab-sub-10.ttl.bz22021-05-12 00:38 493  
[ ]dbr-Tabalumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Tabalumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 205  
[ ]dbr-Tabalumab-sub-10.ttl.bz22021-05-12 00:38 552  
[ ]dbr-Tadocizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 745  
[ ]dbr-Tadocizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tadocizumab-sub-10.ttl.bz22021-05-12 00:38 508  
[ ]dbr-Talizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.5K 
[ ]dbr-Talizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Talizumab-sub-10.ttl.bz22021-05-12 00:38 447  
[ ]dbr-Tanezumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Tanezumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 251  
[ ]dbr-Tanezumab-sub-10.ttl.bz22021-05-12 00:38 565  
[ ]dbr-Tarextumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 847  
[ ]dbr-Tarextumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 184  
[ ]dbr-Tarextumab-sub-10.ttl.bz22021-05-12 00:38 528  
[ ]dbr-Technetium_%2899mTc%29_votumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 882  
[ ]dbr-Technetium_%2899mTc%29_votumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Technetium_%2899mTc%29_votumumab-sub-10.ttl.bz22021-05-12 00:38 520  
[ ]dbr-Tefibazumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 719  
[ ]dbr-Tefibazumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 162  
[ ]dbr-Tefibazumab-sub-10.ttl.bz22021-05-12 00:38 579  
[ ]dbr-Teplizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 944  
[ ]dbr-Teplizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Teplizumab-sub-10.ttl.bz22021-05-12 00:38 538  
[ ]dbr-Teprotumumab-obj-10.ttl.bz22021-05-12 00:38 162  
[ ]dbr-Teprotumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Teprotumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 645  
[ ]dbr-Teprotumumab-sub-10.ttl.bz22021-05-12 00:38 757  
[ ]dbr-Tezepelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Tezepelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tezepelumab-sub-10.ttl.bz22021-05-12 00:38 737  
[ ]dbr-Theralizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.4K 
[ ]dbr-Theralizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 192  
[ ]dbr-Theralizumab-sub-10.ttl.bz22021-05-12 00:38 635  
[ ]dbr-Tigatuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Tigatuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tigatuzumab-sub-10.ttl.bz22021-05-12 00:38 528  
[ ]dbr-Tildrakizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Tildrakizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 245  
[ ]dbr-Tildrakizumab-sub-10.ttl.bz22021-05-12 00:38 800  
[ ]dbr-Tislelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 862  
[ ]dbr-Tislelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 392  
[ ]dbr-Tislelizumab-sub-10.ttl.bz22021-05-12 00:38 526  
[ ]dbr-Tocilizumab-obj-10.ttl.bz22021-05-12 00:38 168  
[ ]dbr-Tocilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Tocilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 233  
[ ]dbr-Tocilizumab-sub-10.ttl.bz22021-05-12 00:38 840  
[ ]dbr-Toralizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Toralizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Toralizumab-sub-10.ttl.bz22021-05-12 00:38 467  
[ ]dbr-Tovetumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 618  
[ ]dbr-Tovetumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tovetumab-sub-10.ttl.bz22021-05-12 00:38 463  
[ ]dbr-Tralokinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.4K 
[ ]dbr-Tralokinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tralokinumab-sub-10.ttl.bz22021-05-12 00:38 612  
[ ]dbr-Trastuzumab-obj-10.ttl.bz22021-05-12 00:38 142  
[ ]dbr-Trastuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 841  
[ ]dbr-Trastuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 272  
[ ]dbr-Trastuzumab-sub-10.ttl.bz22021-05-12 00:38 1.1K 
[ ]dbr-Tregalizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 381  
[ ]dbr-Tregalizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 465  
[ ]dbr-Tregalizumab-sub-10.ttl.bz22021-05-12 00:38 455  
[ ]dbr-Tremelimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 875  
[ ]dbr-Tremelimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 182  
[ ]dbr-Tremelimumab-sub-10.ttl.bz22021-05-12 00:38 571  
[ ]dbr-Trevogrumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 557  
[ ]dbr-Trevogrumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Trevogrumab-sub-10.ttl.bz22021-05-12 00:38 489  
[ ]dbr-Tuvirumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 397  
[ ]dbr-Tuvirumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Tuvirumab-sub-10.ttl.bz22021-05-12 00:38 404  
[ ]dbr-Ulocuplumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 456  
[ ]dbr-Ulocuplumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Ulocuplumab-sub-10.ttl.bz22021-05-12 00:38 433  
[ ]dbr-Urelumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Urelumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 455  
[ ]dbr-Urelumab-sub-10.ttl.bz22021-05-12 00:38 525  
[ ]dbr-Urtoxazumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 601  
[ ]dbr-Urtoxazumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Urtoxazumab-sub-10.ttl.bz22021-05-12 00:38 512  
[ ]dbr-Ustekinumab-obj-10.ttl.bz22021-05-12 00:38 237  
[ ]dbr-Ustekinumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 905  
[ ]dbr-Ustekinumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 265  
[ ]dbr-Ustekinumab-sub-10.ttl.bz22021-05-12 00:38 804  
[ ]dbr-Vantictumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.3K 
[ ]dbr-Vantictumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 45  
[ ]dbr-Vantictumab-sub-10.ttl.bz22021-05-12 00:38 493  
[ ]dbr-Vanucizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.2K 
[ ]dbr-Vanucizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Vanucizumab-sub-10.ttl.bz22021-05-12 00:38 489  
[ ]dbr-Varlilumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Varlilumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 227  
[ ]dbr-Varlilumab-sub-10.ttl.bz22021-05-12 00:38 459  
[ ]dbr-Vatelizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 440  
[ ]dbr-Vatelizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 357  
[ ]dbr-Vatelizumab-sub-10.ttl.bz22021-05-12 00:38 467  
[ ]dbr-Vedolizumab-obj-10.ttl.bz22021-05-12 00:38 234  
[ ]dbr-Vedolizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.0K 
[ ]dbr-Vedolizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 270  
[ ]dbr-Vedolizumab-sub-10.ttl.bz22021-05-12 00:38 937  
[ ]dbr-Veltuzumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Veltuzumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 228  
[ ]dbr-Veltuzumab-sub-10.ttl.bz22021-05-12 00:38 497  
[ ]dbr-Visilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 1.1K 
[ ]dbr-Visilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 142  
[ ]dbr-Visilizumab-sub-10.ttl.bz22021-05-12 00:38 392  
[ ]dbr-Vobarilizumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 468  
[ ]dbr-Vobarilizumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 172  
[ ]dbr-Vobarilizumab-sub-10.ttl.bz22021-05-12 00:38 518  
[ ]dbr-Zalutumumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 858  
[ ]dbr-Zalutumumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 355  
[ ]dbr-Zalutumumab-sub-10.ttl.bz22021-05-12 00:38 594  
[ ]dbr-Zanolimumab-patterns-100-10000-4.yml.bz22021-05-12 00:38 737  
[ ]dbr-Zanolimumab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 00:38 194  
[ ]dbr-Zanolimumab-sub-10.ttl.bz22021-05-12 00:38 488  
Apache/2.4.52 (Ubuntu) Server at webtentacle1.techfak.uni-bielefeld.de Port 80